Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CABA Cabaletta Bio

交易中 12-19 11:55:18 EST

2.41

+0.12

+5.24%

最高2.45	最低2.17	成交量90.18万
今开2.26	昨收2.29	日振幅12.01%
总市值1.18亿	流通市值1.00亿	总股本4,888万
成交额207.03万	换手率2.17%	流通股本4,157万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"CABA","market":"US","secType":"STK","nameCN":"Cabaletta Bio","latestPrice":2.41,"timestamp":1734627313134,"preClose":2.29,"halted":0,"volume":901814,"delay":0,"floatShares":41566005,"shares":48877164,"eps":-2.161992,"marketStatus":"交易中","marketStatusCode":2,"change":0.12,"latestTime":"12-19 11:55:18 EST","open":2.26,"high":2.445,"low":2.17,"amount":2070326.865104,"amplitude":0.120087,"askPrice":2.41,"askSize":1016,"bidPrice":2.4,"bidSize":1613,"shortable":0,"etf":0,"ttmEps":-2.161992,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734642000000},"adr":0,"listingDate":1571976000000,"adjPreClose":2.29,"preHourTrading":{"tag":"盘前","latestPrice":2.3,"preClose":2.29,"latestTime":"09:26 EST","volume":31313,"amount":71940.8315437,"timestamp":1734618392179},"postHourTrading":{"tag":"盘后","latestPrice":2.3403,"preClose":2.29,"latestTime":"19:56 EST","volume":172981,"amount":398865.1673,"timestamp":1734569813472},"volumeRatio":1.503704,"impliedVol":1.487,"impliedVolPercentile":0.623},"requestUrl":"/m/hq/s/CABA","defaultTab":"news","newsList":[{"id":"2492793138","title":"Cabaletta Bio, Inc.盘中异动 早盘快速跳水5.09%报2.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492793138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492793138?lang=zh_cn&edition=full","pubTime":"2024-12-18 23:53","pubTimestamp":1734537196,"startTime":"0","endTime":"0","summary":"北京时间2024年12月18日23时53分，Cabaletta Bio, Inc.股票出现异动，股价快速下挫5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.23%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823531695ea5671&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121823531695ea5671&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2491692432","title":"Cabaletta Bio, Inc.盘中异动 急速下跌5.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2491692432","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491692432?lang=zh_cn&edition=full","pubTime":"2024-12-16 22:31","pubTimestamp":1734359491,"startTime":"0","endTime":"0","summary":"北京时间2024年12月16日22时31分，Cabaletta Bio, Inc.股票出现波动，股价快速下挫5.89%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223131984c7178&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241216223131984c7178&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2491725653","title":"Cabaletta Bio, Inc.盘中异动 急速下跌5.41%报2.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491725653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491725653?lang=zh_cn&edition=full","pubTime":"2024-12-13 23:55","pubTimestamp":1734105337,"startTime":"0","endTime":"0","summary":"北京时间2024年12月13日23时55分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.41%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.46%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323553795e97a79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121323553795e97a79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2490892414","title":"Cabaletta Bio, Inc.盘中异动 股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490892414","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490892414?lang=zh_cn&edition=full","pubTime":"2024-12-12 04:04","pubTimestamp":1733947471,"startTime":"0","endTime":"0","summary":"北京时间2024年12月12日04时04分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.03%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.22%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212040431984b62d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241212040431984b62d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2490712773","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490712773","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2490712773?lang=zh_cn&edition=full","pubTime":"2024-12-09 22:39","pubTimestamp":1733755191,"startTime":"0","endTime":"0","summary":"北京时间2024年12月09日22时39分，Cabaletta Bio, Inc.股票出现异动，股价快速下跌5.31%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.31%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223952984ac531&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241209223952984ac531&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2489457292","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.13%报3.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489457292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2489457292?lang=zh_cn&edition=full","pubTime":"2024-12-05 22:31","pubTimestamp":1733409069,"startTime":"0","endTime":"0","summary":"北京时间2024年12月05日22时31分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.13%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.13%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223109971be129&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241205223109971be129&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":1},{"id":"2488457529","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.08%报3.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488457529","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488457529?lang=zh_cn&edition=full","pubTime":"2024-12-03 22:32","pubTimestamp":1733236327,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日22时32分，Cabaletta Bio, Inc.股票出现异动，股价快速跳水5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.16%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223208971b5de5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203223208971b5de5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":1},{"id":"2488187672","title":"Cabaletta Bio, Inc.股价上涨36.78% 市值涨9392.99万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2488187672","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2488187672?lang=zh_cn&edition=full","pubTime":"2024-12-02 22:32","pubTimestamp":1733149922,"startTime":"0","endTime":"0","summary":"北京时间2024年12月02日22时32分，Cabaletta Bio, Inc.股票出现异动，股价急速上涨36.78%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223202abf000c7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241202223202abf000c7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2487974550","title":"Cabaletta Bio, Inc.盘中异动 早盘快速拉升26.25%报3.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2487974550","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2487974550?lang=zh_cn&edition=full","pubTime":"2024-11-29 22:31","pubTimestamp":1732890672,"startTime":"0","endTime":"0","summary":"北京时间2024年11月29日22时31分，Cabaletta Bio, Inc.股票出现波动，股价快速上涨26.25%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223113a25f7463&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241129223113a25f7463&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2486827036","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2486827036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486827036?lang=zh_cn&edition=full","pubTime":"2024-11-27 22:31","pubTimestamp":1732717872,"startTime":"0","endTime":"0","summary":"北京时间2024年11月27日22时31分，Cabaletta Bio, Inc.股票出现异动，股价快速拉升5.41%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223112abe36972&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223112abe36972&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2486080227","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.35%报1.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486080227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486080227?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:32","pubTimestamp":1732545145,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时32分，Cabaletta Bio, Inc.股票出现波动，股价大幅拉升5.35%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522322598e44640&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112522322598e44640&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2485298979","title":"Cabaletta Bio, Inc.2024财年第三财季实现净利润-30.63百万美元，同比减少86.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485298979","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485298979?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:02","pubTimestamp":1732291348,"startTime":"0","endTime":"0","summary":"11月23日，Cabaletta Bio, Inc.公布财报，公告显示公司2024财年第三财季净利润为-30.63百万美元，同比减少86.20%；其中营业收入为0.00美元，每股基本收益为-0.62美元。从资产负债表来看，Cabaletta Bio, Inc.总负债30.17百万美元，其中短期债务7.94百万美元，资产负债比为0.07，流动比率为0.09。机构评级：截至2024年11月23日，当前有10家机构对Cabaletta Bio, Inc.目标价做出预测，其中目标均价为22.10美元，其中最低目标价为10.00美元，最高目标价为35.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000256abd7b90c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000256abd7b90c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA"],"gpt_icon":0},{"id":"2485826156","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大涨5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485826156","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485826156?lang=zh_cn&edition=full","pubTime":"2024-11-22 22:30","pubTimestamp":1732285851,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日22时30分，Cabaletta Bio, Inc.股票出现异动，股价急速拉升5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051abd79156&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122223051abd79156&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2485418357","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485418357","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485418357?lang=zh_cn&edition=full","pubTime":"2024-11-21 22:59","pubTimestamp":1732201155,"startTime":"0","endTime":"0","summary":"北京时间2024年11月21日22时59分，Cabaletta Bio, Inc.股票出现异动，股价急速跳水5.09%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121225915971a7e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241121225915971a7e66&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2484117421","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.12%报2.41美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484117421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484117421?lang=zh_cn&edition=full","pubTime":"2024-11-20 22:36","pubTimestamp":1732113396,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日22时36分，Cabaletta Bio, Inc.股票出现波动，股价急速下挫5.12%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.03%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223636971a7ae3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120223636971a7ae3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2484676523","title":"Cabaletta Bio, Inc.盘中异动 大幅下跌5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2484676523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484676523?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:42","pubTimestamp":1731940949,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时42分，Cabaletta Bio, Inc.股票出现波动，股价大幅跳水5.61%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224229971a72dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118224229971a72dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2483630089","title":"美国研究综述-应用材料公司、迪士尼、沃尔玛","url":"https://stock-news.laohu8.com/highlight/detail?id=2483630089","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483630089?lang=zh_cn&edition=full","pubTime":"2024-11-16 01:28","pubTimestamp":1731691712,"startTime":"0","endTime":"0","summary":"美国研究综述-应用材料公司、迪士尼、沃尔玛路透11月15日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，其中包括应用材料公司、迪士尼和沃尔玛。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241115:nL4T3MM1DA:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AESI","AIN","SCHW","BRZE","LU1861217088.USD","CHX","LNG","AAP","ASND","IE00BBT3K403.USD","BIIB","BMY","BJ","BKR","BTM","BK4534","LU0354030511.USD","BL","AROC","ARE","AMAT","LU1074936037.SGD","AFG","BK4588","BV","ALGT","LU1032466523.USD","ADSK","BLUE","AKYA","AAL","ASB","AMH","ALK","AGYS","BE","BRX","ASTS","LU1267930227.SGD","AGCO","AHR","AHCO","CABA","APH","BAC","LU0868494708.USD","IE00BKVL7J92.USD","ARI","CELC","CAVA"],"gpt_icon":1},{"id":"2483372214","title":"Cabaletta Bio, Inc.盘中异动 早盘股价大跌5.16%报3.59美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483372214","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483372214?lang=zh_cn&edition=full","pubTime":"2024-11-15 22:33","pubTimestamp":1731681236,"startTime":"0","endTime":"0","summary":"北京时间2024年11月15日22时33分，Cabaletta Bio, Inc.股票出现异动，股价大幅下挫5.16%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为1.31%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522335798e42ed3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111522335798e42ed3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CABA"],"gpt_icon":0},{"id":"2483806264","title":"卡巴莱塔生物公司公布本季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2483806264","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483806264?lang=zh_cn&edition=full","pubTime":"2024-11-14 22:16","pubTimestamp":1731593773,"startTime":"0","endTime":"0","summary":"   * Cabaletta Bio Inc   报告本季度调整后每股亏损62美分，低于去年同期的每股收益-37美分。11位分析师对该季度的平均预期是每股亏损60美分。华尔街预期为每股-64美分至-54美分。* Cabaletta Bio Inc 公布的本季度每股收益为亏损 62 美分。* 公司报告的季度亏损额为 3,063 万美元。* Cabaletta Bio Inc 本季度股价下跌了 15.0%，今年迄今为止亏损了 82.3%。华尔街对卡巴莱塔生物公司 12 个月目标价的中位数为 24.00  本摘要由 LSEG 11 月 14 日 02:15 p.m. UTC 数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"卡巴莱塔生物公司公布本季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CABA","BK4139"],"gpt_icon":0},{"id":"2483385504","title":"Cabaletta Bio, Inc.盘中异动 股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483385504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483385504?lang=zh_cn&edition=full","pubTime":"2024-11-14 02:51","pubTimestamp":1731523891,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日02时51分，Cabaletta Bio, Inc.股票出现波动，股价快速跳水5.08%。Cabaletta Bio, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。Cabaletta Bio, Inc.公司简介：Cabaletta Bio Inc 是一家临床阶段的生物技术公司，专注于发现和开发工程化 T 细胞疗法，并探索它们为 B 细胞介导的自身免疫性疾病患者提供深度和持久的、可能是治愈性治疗的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025131971a65b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114025131971a65b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CABA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cabalettabio.com","stockEarnings":[{"period":"1week","weight":-0.2529},{"period":"1month","weight":-0.1519},{"period":"3month","weight":-0.5128},{"period":"6month","weight":-0.73},{"period":"1year","weight":-0.8975},{"period":"ytd","weight":-0.8991}],"compareEarnings":[{"period":"1week","weight":-0.0349},{"period":"1month","weight":-0.0032},{"period":"3month","weight":0.0268},{"period":"6month","weight":0.0767},{"period":"1year","weight":0.2347},{"period":"ytd","weight":0.2335}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cabaletta Bio, Inc.于2017年4月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司，专注于发现和开发工程化T细胞疗法，这些疗法有可能为患有自身免疫性疾病的患者提供一种深度和持久的，也许是治疗性的治疗。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.047408},{"month":2,"riseRate":0.2,"avgChangeRate":-0.139771},{"month":3,"riseRate":0.2,"avgChangeRate":-0.173851},{"month":4,"riseRate":0.4,"avgChangeRate":-0.089046},{"month":5,"riseRate":0.4,"avgChangeRate":0.011007},{"month":6,"riseRate":0.4,"avgChangeRate":-0.019407},{"month":7,"riseRate":0.6,"avgChangeRate":0.002175},{"month":8,"riseRate":0.4,"avgChangeRate":-0.014107},{"month":9,"riseRate":0.6,"avgChangeRate":-0.036797},{"month":10,"riseRate":0.6,"avgChangeRate":0.296033},{"month":11,"riseRate":0.833333,"avgChangeRate":0.381738},{"month":12,"riseRate":0.5,"avgChangeRate":0.044041}],"exchange":"NASDAQ","name":"Cabaletta Bio","nameEN":"Cabaletta Bio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cabaletta Bio,CABA,Cabaletta Bio股票,Cabaletta Bio股票老虎,Cabaletta Bio股票老虎国际,Cabaletta Bio行情,Cabaletta Bio股票行情,Cabaletta Bio股价,Cabaletta Bio股市,Cabaletta Bio股票价格,Cabaletta Bio股票交易,Cabaletta Bio股票购买,Cabaletta Bio股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cabaletta Bio(CABA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cabaletta Bio(CABA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}